Abstract
We have generated a recombinant influenza A virus with the HIV-1 p17(Gag) (rFlu-p17) gene inserted into the influenza virus neuraminidase (NA) gene. Expression of HIV-1 p17 protein was detected by conventional Western blot analysis and also by liquid chromatography/tandem mass spectrometry (LC-MS/MS) analysis of rFlu-p17 infected cells. The latter method does not depend on protein-specific antibody preparations and proved to be a powerful tool to detect proteins of interest. Next, antigen presentation of p17 expressed after infection of antigen-presenting cells was determined. Cloned p17-specific CD8+ T-cells were co-cultured with rFlu-p17 infected B-cells and produced IFN-gamma upon stimulation. Furthermore, we showed that immunization with rFlu-p17 elicited a humoral immune response in mice. This study shows that replication-deficient rFlu-p17 is antigenic in vitro and immunogenic in vivo and warrants further development as a candidate vaccine vector. (C) 2009 Elsevier Ltd. All rights reserved.
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 5735-5739 |
Number of pages | 5 |
Journal | Vaccine |
Volume | 27 |
Issue number | 42 |
DOIs | |
Publication status | Published - 2009 |
Research programs
- EMC MM-03-44-06
- EMC MM-04-27-01
- EMC OR-01-34-01